Innoviva (INVA) Revenue Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3,790.58% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 10.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.56% |
| Dec 31, 2025 | -12.15% |
| Sep 30, 2025 | 20.44% |
| Jun 30, 2025 | 0.39% |
| Mar 31, 2025 | 9,075.16% |
| Dec 31, 2024 | -19.18% |
| Sep 30, 2024 | 33.08% |
| Jun 30, 2024 | 10,093.67% |
| Mar 31, 2024 | 21.36% |
| Dec 31, 2023 | 45.39% |
| Sep 30, 2023 | 5,073.77% |
| Jun 30, 2023 | -47.96% |
| Mar 31, 2023 | -35.60% |
| Dec 31, 2022 | 6.27% |
| Sep 30, 2022 | -98.67% |
| Jun 30, 2022 | 61.22% |
| Mar 31, 2022 | 15.95% |
| Dec 31, 2021 | 96.23% |
| Sep 30, 2021 | 10.34% |
| Jun 30, 2021 | -98.52% |
| Mar 31, 2021 | -98.65% |
| Dec 31, 2020 | -99.34% |
| Sep 30, 2020 | 34.89% |
| Jun 30, 2020 | 23.15% |
| Mar 31, 2020 | 42.58% |
| Dec 31, 2019 | -4.87% |
| Sep 30, 2019 | 6.61% |
| Jun 30, 2019 | -4.44% |
| Mar 31, 2019 | 5.35% |
| Dec 31, 2018 | 14.87% |
| Sep 30, 2018 | 26.80% |
| Jun 30, 2018 | 14.56% |
| Mar 31, 2018 | 29.36% |
| Dec 31, 2017 | 59.41% |
| Sep 30, 2017 | 46.04% |
| Jun 30, 2017 | 80.35% |
| Mar 31, 2017 | 67.49% |
| Dec 31, 2016 | 90.98% |
| Sep 30, 2016 | 145.61% |
| Jun 30, 2016 | 204.76% |
| Mar 31, 2016 | 250.58% |
| Dec 31, 2015 | 213.68% |
| Sep 30, 2015 | 1,257.56% |
| Jun 30, 2015 | 1,040.79% |
| Mar 31, 2015 | 784.10% |
| Dec 31, 2014 | 394.23% |
| Sep 30, 2014 | 140.72% |
| Jun 30, 2014 | -29.35% |
| Mar 31, 2014 | -41.00% |
| Dec 31, 2013 | 101.18% |
| Sep 30, 2013 | -70.98% |
| Jun 30, 2013 | 152.77% |
| Mar 31, 2013 | -98.95% |
| Dec 31, 2012 | -2,419.04% |
| Sep 30, 2012 | -77.76% |
| Jun 30, 2012 | -91.81% |
| Mar 31, 2012 | 1,887.05% |